Cellectis (CLLS) Tops Q2 EPS by 4c

Cellectis (NASDAQ: CLLS) reported Q2 EPS of ($0.22), $0.04 better than the analyst estimate of ($0.26). Revenue for the quarter came in at $6.9 million versus the consensus estimate of $10.97 million.

For earnings history and earnings-related data on Cellectis (CLLS) click here.

You May Also Be Interested In

• Barrick Mining said to delay IPO of American gold business to 2027
• Varonis Systems (VRNS) Halted on Volatility
• Franklin Dentist, The Opal Dental Co., Relocates to New Franklin, WI, Marking New Operational Milestone